Arq Neuropsiquiatr. 2003
Mar;61(1):146-52. Epub 2003 Apr 16.
[Transcranial
magnetic stimulation]
[Article in Portuguese]
Conforto AB, Marie SK, Cohen LG, Scaff M.
Divisao de Clinica Neurologica, Hospital das Clinicas,
Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo,
SP, Brasil.
Hum Psychopharmacol 2002
Oct;17(7):353-6
Combining
high
and
low frequencies in rTMS antidepressive treatment:
preliminary results.
Conca A, Di Pauli J, Beraus W, Hausmann A, Peschina W,
Schneider H, Konig P, Hinterhuber H. Departments of
Psychiatry I and II, Regional Hospital, 6830 Rankweil,
Austria.
J Clin Neurophysiol 2002
Aug;19(4):272-93
Applications
of
transcranial
magnetic stimulation in movement disorders.
Cantello R.
Department of Medical Sciences, Section of Neurology,
School of Medicine, Amedeo Avogadro University, Novara,
Italy.
Neuropharmacology 2002
Jul;43(1):101-9
Repetitive
transcranial
magnetic
stimulation increases the release of dopamine in the
mesolimbic and mesostriatal system.
Keck ME, Welt T, Muller MB, Erhardt A, Ohl F, Toschi N,
Holsboer F, Sillaber I.
Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10,
80804, Munich, Germany.
Mov Disord 2002
May;17(3):528-32
Therapeutic
efficacy
of
bilateral prefrontal slow repetitive transcranial magnetic
stimulation in depressed patients with Parkinson's
disease: an open study.
Dragasevic N, Potrebic A, Damjanovic A, Stefanova E, Kostic
VS.
Institute of Neurology Clinical Center of Serbia, Medical
School, Belgrade, Yugoslavia.
Neurology 2002 Apr
23;58(8):1288-90
Improved
executive
functioning
following repetitive transcranial magnetic stimulation.
Moser DJ, Jorge RE, Manes F, Paradiso S, Benjamin ML,
Robinson RG.
Department of Psychiatry, University of Iowa College of
Medicine, Iowa City, IA 52240, USA.
Biol Psychiatry 2002 Apr
15;51(8):687-90
Three
and
six-month
outcome following courses of either ECT or rTMS in a
population of severely depressed individuals--preliminary
report.
Dannon PN, Dolberg OT, Schreiber S, Grunhaus L.
Psychiatry Division, ECT-TMS Unit, Chaim Sheba Medical
Center, 52621 Tel Hashomer, Israel.
Encephale 2002
Mar-Apr;28(2):169-75
[Transcranial
magnetic
stimulation
in depression]
[Article in French]
Saba G, Januel D, Glikman J.
Psychiatre, assistant, Unite de Recherche clinique, Secteur
III, Service du docteur Glikman, EPS de Ville Evrard, 5, rue
du Docteur Delafontaine, 93200 Saint-Denis, France.
Arch Neurol 2002
Mar;59(3):413-7
Transcranial
magnetic
stimulation
of the cerebellum in essential tremor: a controlled study.
Gironell A, Kulisevsky J, Lorenzo J, Barbanoj M,
Pascual-Sedano B, Otermin P.
Servei de Neurologia, Hospital de Sant Pau, Av Sant Antoni
Ma Claret 167, 08025
Nervenarzt 2001
Dec;72(12):932-8
[Contralateral
and
ipsilateral
repetitive transcranial magnetic stimulation in Parkinson
patients]
[Article in German]
de Groot M, Hermann W, Steffen J, Wagner A, Grahmann F.
Klinik und Poliklinik fur Neurologie, Universitatsklinikum
Leipzig, Liebigstrasse 22a, 04103 Leipzig.
Srp Arh Celok Lek 2001
Sep-Oct;129(9-10):235-8
[Effect
of
slow
repetitive transcranial magnetic stimulation on depression
in patients with Parkinson 's disease]
[Article in Serbo-Croatian (Cyrillic)]
Potrebic A, Dragasevic N, Svetel M, Kostic VS.
Institute of Psychiatry, Clinical Centre of Serbia,
Belgrade.
J Affect Disord 2001
Sep;66(1):83-8
The
impact
of
repetitive transcranial magnetic stimulation on pituitary
hormone levels and cortisol in healthy subjects.
Evers S, Hengst K, Pecuch PW.
Department of Neurology, University of Munster,
Albert-Schweitzer-Str. 33, 48129 Munster, Germany.
J Neurol 2001 Sep;248 Suppl
3:III48-52
Therapeutic
effect
and
mechanism of repetitive transcranial magnetic stimulation
in Parkinson's disease.
Shimamoto H, Takasaki K, Shigemori M, Imaizumi T, Ayabe M,
Shoji H.
Shimamoto Neurosurgical Clinic, Kurume University School of
Medicine, Ohnojo-city, Fukuoka, Japan.
Psychopharmacol Bull 2001
Autumn;35(4):149-69
A
meta-analysis of repetitive transcranial magnetic
stimulation in the treatment of depression.
Holtzheimer PE 3rd, Russo J, Avery DH.
Department of Psychiatry and Behavioral Sciences,
University of Washington Medical Center, Harborview Medical
Center, 325 Ninth Avenue, Box 359896, Seattle, WA 98104,
USA.
J Neurosci 2001 Aug
1;21(15):RC157
Repetitive
transcranial
magnetic
stimulation of the human prefrontal cortex induces
dopamine release in the caudate nucleus.
Strafella AP, Paus T, Barrett J, Dagher A.
Montreal Neurological Institute, McGill University,
Montreal, Quebec, Canada H3A 2B4.
Neurosci Lett 2001 May
11;303(3):165-8
Striatal
dopaminergic
metabolism
is increased by deep brain stimulation of the subthalamic
nucleus in 6-hydroxydopamine lesioned rats.
Meissner W, Reum T, Paul G, Harnack D, Sohr R, Morgenstern
R, Kupsch A.
Department of Neurology, Charite Campus Virchow-Klinikum,
Humboldt-University Berlin, Augustenburger Platz 1, 13353,
Berlin, Germany.
Biol Psychiatry 2001 Jul
1;50(1):22-7
Acute
mood
and
thyroid stimulating hormone effects of transcranial
magnetic stimulation in major depression.
Szuba MP, O'Reardon JP, Rai AS, Snyder-Kastenberg J,
Amsterdam JD, Gettes DR, Wassermann E, Evans DL.
University of Pennsylvania, Department of Psychiatry,
Philadelphia, Pennsylvania 19104, USA.
Brain Topogr 2000
Winter;13(2):135-44
Nonlinear
analysis
of
brain activity in magnetic influenced Parkinson patients.
Anninos PA, Adamopoulos AV, Kotini A, Tsagas N.
Dept. of Medicine, Demokrition University of Thrace,
Alexandroupolis, Greece.
Nippon Rinsho. 2000
Oct;58(10):2120-4.
[Parkinson's disease and depression]
[Article in Japanese]
Kurokawa K, Yuasa T.
Department of Neurology, Kohnodai Hospital.
Up to 40% of cases of Parkinson's disease are associated with
the occurrence of depression. The symptoms of the patients'
depressive state may be factors such as significant weight
change, insomnia or hypersomnia, psychomotor retardation,
fatigue or loss of energy, feelings of worthlessness or
inappropriate guilt, decreased concentration and
indecisiveness, and recurrent thoughts of death or suicidal
ideation. Given these conditions, drugs prove ineffective in
many cases. Electroconvulsive therapy (ECT) has been reported
to be beneficial in cases of drug-resistant depression. ECT
has also been applied to Parkinsonian patients with depression
and found to be effective with both depression and the
Parkinsonian symptom. Transcranial magnetic stimulation(TMS)
has recently been investigated for application in cases of
depression and has become known as a valuable tool for
depression therapy. TMS is easily implemented even in
outpatient therapy. TMS will make a great contribution to the
therapy of depression with Parkinson's disease.
Int J Neurosci. 1998
Sep;95(3-4):255-69.
Reversal
of
the
bicycle drawing direction in Parkinson's disease by AC
pulsed electromagnetic fields.
Sandyk R.
Department of Neuroscience, Touro College, Dix Hills, NY
11746, USA.
Int J Neurosci. 1998
Feb;93(1-2):43-54.
Reversal
of
a
body image disorder (macrosomatognosia) in Parkinson's
disease by treatment with AC pulsed electromagnetic
fields.
Sandyk R.
Department of Neuroscience, Institute for Biomedical
Engineering and Rehabilitation Services of Touro College,
Dix Hills, NY 11746, USA.
Int J Neurosci. 1997
Nov;92(1-2):63-72.
Speech
impairment
in
Parkinson's disease is improved by transcranial
application of electromagnetic fields.
Sandyk R.
Department of Neuroscience, Touro College, Dix Hills, NY
11746, USA.
Int J Neurosci. 1997
Oct;91(3-4):189-97.
Treatment
with
AC
pulsed electromagnetic fields improves the response to
levodopa in Parkinson's disease.
Sandyk R.
Department of Neuroscience, Touro College, Dix Hills, NY
11746, USA.
Int J Neurosci. 1997
Sep;91(1-2):57-68.
Reversal
of
cognitive
impairment in an elderly parkinsonian patient by
transcranial application of picotesla electromagnetic
fields.
Sandyk R.
Department of Neuroscience, Touro College, Dix Hills, NY
11746, USA.
Int J Neurosci. 1996
Mar;85(1-2):111-24.
Freezing
of
gait
in Parkinson's disease is improved by treatment with weak
electromagnetic fields.
Sandyk R.
NeuroCommunication Research Laboratories, Danbury, CT
06811, USA.
Int J Neurosci. 1995
Jun;82(3-4):255-68.
Reversal
of
visuospatial
deficit on the Clock Drawing Test in Parkinson's disease
by treatment with weak electromagnetic fields.
Sandyk R.
Panminerva Med. 1995
Jun;37(2):98-104.
A
physical mechanism in the treatment of neurologic
disorders with externally applied pico Tesla magnetic
fields.
Jacobson JI, Yamanashi WS.
Institute of Theoretical Physics and Advanced Studies for
Biophysical Research, Jupiter, FL 33477-1418, USA.
Int J Neurosci. 1995
Mar;81(1-2):67-82.
Improvement
in
short-term
visual memory by weak electromagnetic fields in
Parkinson's disease.
Sandyk R.
NeuroCommunication Research Laboratories, Danbury, CT
06811, USA.
Int J Neurosci. 1995
Mar;81(1-2):47-65.
Weak
electromagnetic
fields
reverse visuospatial hemi-inattention in Parkinson's
disease.
Sandyk R.
NeuroCommunication Research Laboratories, Danbury, CT
06811, USA.
Panminerva Med 1994
Dec;36(4):201-5
Pineal-hypothalamic
tract
mediation
of picotesla magnetic fields in the treatment of
neurological disorders.
Jacobson JI.
Institute of Theoretical Physics and Advanced Studies for
Biophysical Research, Jupiter, FL
Int J Neurosci. 1994
Nov;79(1-2):99-110.
A
drug naive parkinsonian patient successfully treated with
weak electromagnetic fields.
Sandyk R.
NeuroCommunication Research Laboratories, Danbury, CT
06811, USA.
Int J Neurosci. 1994
Jul;77(1-2):23-46.
Improvement
in
word-fluency
performance in Parkinson's disease by administration of
electromagnetic fields.
Sandyk R.
Neuro Communication Research Laboratories, Danbury, CT
06811.
Neurology 1994
May;44(5):892-8
Akinesia
in
Parkinson's
disease. II. Effects of subthreshold repetitive
transcranial motor cortex stimulation.
Pascual-Leone A, Valls-Sole J, Brasil-Neto JP, Cammarota A,
Grafman J, Hallett M.
Human Cortical Physiology Unit, National Institute of
Neurological Disorders and Stroke, National Institutes of
Health, Bethesda, MD 20892.
Int J Neurosci. 1993
Jun;70(3-4):233-54.
Rapid
improvement
of
visuoperceptive functions by picoTesla range magnetic
fields in patients with Parkinson's disease.
Sandyk R, Iacono RP.
Int J Neurosci. 1993
May;70(1-2):85-96.
The
effects
of
external picoTesla range magnetic fields on the EEG in
Parkinson's disease.
Sandyk R, Derpapas K.
NeuroCommunication Research Laboratories, Danbury, CT
06811.
Int J Neurosci. 1993
Mar-Apr;69(1-4):167-83.
Further
observations
on
the unique efficacy of picoTesla range magnetic fields in
Parkinson's disease.
Sandyk R, Derpapas K.
NeuroCommunication Research Laboratories, Danbury, CT
06811.
Int J Neurosci. 1993
Jan;68(1-2):85-91.
Weak
magnetic
fields
antagonize the effects of melatonin on blood glucose
levels in Parkinson's disease.
Sandyk R.
Department of Medical Physics, University of Thrace,
Alexandroupolis, Greece.
Int J Neurosci. 1992
Oct;66(3-4):209-35.
Magnetic
fields
in
the therapy of parkinsonism.
Sandyk R.
NeuroCommunication Research Laboratories, Danbury, CT
06811.
Int J Neurosci 1992
Mar;63(1-2):141-50
Magnetic
fields
in
the treatment of Parkinson's disease.
Sandyk R, Anninos PA, Tsagas N, Derpapas K.
Democrition University of Thrace, Department of Medical
Physics and Polytechnic School, Alexandroupolis and Xanthi,
Greece.